Like many newer therapies, NeuroStar Advanced TMS therapy is finding new applications. It was first FDA-cleared in 2008 for treating treatment-resistant depression (TRD) in adults. Since then, additional FDA clearances have been granted for its use as a first-line add-on treatment for depression in adolescents, for anxiety symptoms related to depression in adults, and as an adjunct therapy for treating obsessive-compulsive disorder (OCD) in adults. Learn more about the specifics of the conditions treated by Auburn NeuroStar TMS therapy by connecting with our trusted team.
More patients are seeking non-medication treatments for depression, often due to limited effectiveness or unwanted side effects from prescription drugs. NeuroStar TMS offers a solution with minimal to no side effects, and over 83 percent of patients who complete a treatment cycle experience significant improvement. In fact, 62 percent of those patients experience remission of their depression. If symptoms return, TMS therapy can be repeated, and maintenance sessions can be scheduled to prevent relapses.*
TMS is an in-office treatment that lasts about 20 minutes per session. Once your session is over, you can immediately resume your normal activities. Any side effects are typically mild, easily managed, and often subside as the treatment progresses.
When your child is struggling with depression, finding relief becomes your top priority. Just as with adults, medications and therapy are not always enough for teenagers. NeuroStar TMS therapy has been FDA-cleared as a first-line add-on treatment for adolescents aged 15 and older. Research suggests that TMS can be an excellent supplemental treatment when traditional methods do not provide fast or effective results for young patients.
Depression often goes hand-in-hand with anxiety. Research has shown that patients with both conditions are more likely to experience treatment-resistant depression. However, clinicians have observed that patients undergoing TMS therapy for depression often see improvements in their anxiety as well. Studies indicate that 70 to 80 percent of adult patients with anxious depression who complete a treatment cycle experience significant relief. About 50 percent of these patients achieve remission from anxiety.
For the 40 percent of adults with obsessive-compulsive disorder (OCD) whose symptoms are not adequately managed by medications and cognitive behavioral therapy (CBT), NeuroStar TMS therapy can offer hope. In the last decade, researchers have refined techniques to specifically target areas of the brain involved in OCD. Stimulating these areas with TMS has been shown to significantly reduce OCD symptoms, providing a much-needed option for our Auburn patients who have not found success with more conventional treatments.
At Beautiful Minds Medical, we treat you as a whole person, not just a collection of symptoms. While we aim to relieve mental health symptoms, we also focus on identifying the underlying causes and addressing other aspects of your life. Your treatment plan is customized to meet your unique needs, and TMS therapy may be one of the tools we use to help you. While TMS improves brain function and reduces symptoms, you will also work on enhancing other areas of your life for overall well-being.
If you are struggling with depression, anxious depression, or OCD, it may be time to explore NeuroStar TMS therapy. While medications and talk therapy are effective for many, they do not work for everyone. TMS therapy may seem futuristic, but it is already making a difference for people around the world. Schedule an appointment with Beautiful Minds Medical to learn more about the conditions treated by Auburn NeuroStar TMS therapy and this treatment could help you achieve lasting mental wellness.
*Outcomes Registry data was published by Sackeim HA, et al. J Affective Disorders, 2020, 277(12):65-74. The outcomes reported represent the subset of study patients for which the CGI-S data was reported before and after an acute course of NeuroStar TMS. Patients were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score <=3 and “complete remission” was defined as a CGI-S score <=2 at the end of treatment.
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.
